Setting new standards in glaucoma treatment

lvantis, Inc. is a company committed to expanding patient treatment and improving outcomes through innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.

Next-generation technology

Offering next-generation MIGS technology that addresses unmet needs in the global glaucoma market.

Improved patient experience

Committed to improving glaucoma patient outcomes using evidence-based research.

Unparalleled clinical data

Collaborating with clinical experts to generate unequivocal clinical evidence through precisely designed, ANSI standard clinical trials.

Please Select Your Country

Continue